Skip to content
drillr.ai

BLFS

BioLife Solutions, Inc.

NASDAQ · USHealthcareMedical - Instruments & Supplies
$29.09-0.21%

Price as of Jul 20, 2026

BLFS news

BioLife Solutions, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. BioLife Solutions Reports First Quarter 2026 Financial Results

    BioLife Solutions Reports First Quarter 2026 Financial Results PR Newswire BOTHELL, Wash., May 7, 2026 Total revenue of $27.5 million, up 25% over Q1 2025 GAAP gross margin and non-GAAP adjusted gross margin of 64% GAAP net income of $1.2 million and non-GAAP adjusted EBITDA of $6.2 million or 22% of revenue Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash., May 7, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4683721-1&h=

    PR Newswire ·

  2. BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

    BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 PR Newswire BOTHELL, Wash., April 23, 2026 BOTHELL, Wash., April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4672198-1&h=1925458534&u=https%3A%2F%2Fbiolifesolutions.com%2F&a=BioLife+Solutions%2C+Inc.)  (NASDAQ: BLFS (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4672198-1&h=1316858371&u=https%3A%2F%2Finvestors.biolifesolutions.com%2Fwelcome&

    PR Newswire ·

  3. BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase

    BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase PR Newswire BOTHELL, Wash., April 21, 2026 Award Recognizes Technologies That Address Important Industry Needs and Advance Prior Standards BOTHELL, Wash., April 21, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4669869-1&h=2961735738&u=https%3A%2F%2Fbiolifesolutions.com%2F&a=BioLife+Solutions%2C+Inc.) (NASDAQ: BLFS (https://edge.prnewswire.com/c/link/?t=0&l=en&

    PR Newswire ·